TickerFacts.

Meihua International Medical Technologies Co., Ltd. (MHUAF): Operating Cash Flow

Annual figures by period end, from SEC filings.

$569.9K
Year ended 2025-12-31
-36.0%
5-year compound annual growth
$14.64M2019-12-31: $9.31M2020-12-31: $5.33M2021-12-31: -$54.7K2022-12-31: -$9.16M2023-12-31: $2.28M2024-12-31: $14.64M2025-12-31: $569.9K$569.9K
2019-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$569.9K-96.1%2026-04-29, From 2025-01-01
2024-12-31$14.64M+543.2%2026-04-29, From 2024-01-01
2023-12-31$2.28Mn/m2026-04-29, From 2023-01-01
2022-12-31-$9.16Mn/m2025-04-25, From 2022-01-01
2021-12-31-$54.7Kn/m2024-04-24, From 2021-01-01
2020-12-31$5.33M-42.8%2023-08-29, From 2020-01-01
2019-12-31$9.31Mn/a2022-07-29, From 2019-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Meihua International Medical Technologies Co., Ltd. (MHUAF)2025-12-31$569.9K-96.1%
LENSAR, Inc. (LNSR)2025-12-31-$14.83Mn/m
CVRx, Inc. (CVRX)2025-12-31-$40.17Mn/m
AVITA Medical, Inc. (RCEL)2025-12-31-$31.20Mn/m
Apyx Medical Corp (APYX)2025-12-31-$8.00Mn/m
Carlsmed, Inc. (CARL)2025-12-31-$28.98Mn/m
Sight Sciences, Inc. (SGHT)2025-12-31-$29.69Mn/m
PRO DEX Inc (PDEX)2026-06-30$7.24Mn/m
TELA Bio, Inc. (TELA)2025-12-31-$28.22Mn/m

Compare MHUAF, LNSR, CVRX, RCEL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗